These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9738873)

  • 21. Laboratory diagnosis of the neuromuscular glycogen storage diseases.
    Farmer PM
    Ann Clin Lab Sci; 1982; 12(6):431-8. PubMed ID: 6817693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe form of juvenile type II glycogenosis in a compound-heterozygous boy (Tyr-292--> Cys/Arg-854-->Stop)].
    Castro-Gago M; Eirís-Puñal J; Rodríguez-Núñez A; Pintos-Martínez E; Benlloch-Marín T; Barros-Angueira F
    Rev Neurol; 1999 Jul 1-15; 29(1):46-9. PubMed ID: 10528311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients.
    Park HD; Lee DH; Choi TY; Lee YK; Lee SY; Kim JW; Ki CS; Lee YW
    Ann Clin Lab Sci; 2013; 43(3):311-6. PubMed ID: 23884227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chorionic villi ultrastructure in the prenatal diagnosis of glycogenosis type II.
    San Millan B; Teijeira S; Domínguez C; Vieitez I; Navarro C
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S105-11. PubMed ID: 20157781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
    Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
    Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening for Pompe disease in Japan.
    Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
    Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiography of glycogen storage diseases.
    Miller JH; Stanley P; Gates GF
    AJR Am J Roentgenol; 1979 Mar; 132(3):379-87. PubMed ID: 106640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations.
    Palmer RE; Amartino HM; Niizawa G; Blanco M; Pomponio RJ; Chamoles NA
    Neuromuscul Disord; 2007 Jan; 17(1):16-22. PubMed ID: 17056254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pompe's disease in identical twins.
    Agarwala BN
    Hosp Pract (Off Ed); 1986 Mar; 21(3A):146-8, 153, 156-8. PubMed ID: 3081558
    [No Abstract]   [Full Text] [Related]  

  • 30. A family with pseudodeficiency of acid alpha-glucosidase.
    Nishimoto J; Inui K; Okada S; Ishigami W; Hirota S; Yamano T; Yabuuchi H
    Clin Genet; 1988 Apr; 33(4):254-61. PubMed ID: 3282727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited.
    Schoser BG; Müller-Höcker J; Horvath R; Gempel K; Pongratz D; Lochmüller H; Müller-Felber W
    Neuropathol Appl Neurobiol; 2007 Oct; 33(5):544-59. PubMed ID: 17573812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal diagnosis of glycogen storage disease type II: enzyme assay or mutation analysis?
    Kleijer WJ; van der Kraan M; Kroos MA; Groener JE; van Diggelen OP; Reuser AJ; van der Ploeg AT
    Pediatr Res; 1995 Jul; 38(1):103-6. PubMed ID: 7478785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two extremes of the clinical spectrum of glycogen storage disease type II in one family: a matter of genotype.
    Kroos MA; Van der Kraan M; Van Diggelen OP; Kleijer WJ; Reuser AJ
    Hum Mutat; 1997; 9(1):17-22. PubMed ID: 8990003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-based diagnostic testing for Pompe disease: consistency between GAA enzyme activity in dried blood spots and GAA gene sequencing results.
    Goldstein JL; Dickerson G; Kishnani PS; Rehder C; Bali DS
    Muscle Nerve; 2014 May; 49(5):775-6. PubMed ID: 24338800
    [No Abstract]   [Full Text] [Related]  

  • 35. Control of generalised glycogenosis in a Brahman herd.
    Healy PJ; Sewell CA; Nieper RE; Whittle RJ; Reichmann KG
    Aust Vet J; 1987 Sep; 64(9):278-80. PubMed ID: 3480704
    [No Abstract]   [Full Text] [Related]  

  • 36. Parental genetic contribution to mode of presentation in Pompe disease.
    Cottrill CM; Johnson GL; Noonan JA
    Pediatrics; 1987 Mar; 79(3):379-81. PubMed ID: 3469615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterozygote detection in a family of Lapland dogs with a recessively inherited metabolic disease: canine glycogen storage disease type II.
    Walvoort HC; Koster JF; Reuser AJ
    Res Vet Sci; 1985 Mar; 38(2):174-8. PubMed ID: 3923581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homozygous deletion of exon 18 leads to degradation of the lysosomal alpha-glucosidase precursor and to the infantile form of glycogen storage disease type II.
    Ausems MG; Kroos MA; Van der Kraan M; Smeitink JA; Kleijer WJ; Ploos van Amstel HK; Reuser AJ
    Clin Genet; 1996 Jun; 49(6):325-8. PubMed ID: 8884087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A family with Pompe's disease (glycogenesis type II).
    Lamabadusuriya SP; Canagarayar UT; Vijeyaratnam G
    Ceylon Med J; 1979; 24(1-2):42-4. PubMed ID: 299071
    [No Abstract]   [Full Text] [Related]  

  • 40. Pompe disease: early diagnosis and early treatment make a difference.
    Chien YH; Hwu WL; Lee NC
    Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.